BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21062671)

  • 1. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
    Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
    J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling.
    Tsai AC; Pan SL; Lai CY; Wang CY; Chen CC; Shen CC; Teng CM
    J Nutr Biochem; 2011 Jul; 22(7):625-33. PubMed ID: 20951021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
    Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
    Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denbinobin, a phenanthrene from dendrobium nobile, inhibits invasion and induces apoptosis in SNU-484 human gastric cancer cells.
    Song JI; Kang YJ; Yong HY; Kim YC; Moon A
    Oncol Rep; 2012 Mar; 27(3):813-8. PubMed ID: 22089965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
    Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
    Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.
    Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH
    Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
    Hingorani P; Zhang W; Gorlick R; Kolb EA
    Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1.
    Strell C; Lang K; Niggemann B; Zaenker KS; Entschladen F
    Exp Cell Res; 2010 Jan; 316(1):138-48. PubMed ID: 19747913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity.
    Huang YC; Guh JH; Teng CM
    J Biomed Sci; 2005; 12(1):113-21. PubMed ID: 15864744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
    Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R
    Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS.
    Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK
    J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
    Chen JY; Tang YA; Huang SM; Juan HF; Wu LW; Sun YC; Wang SC; Wu KW; Balraj G; Chang TT; Li WS; Cheng HC; Wang YC
    Cancer Res; 2011 Jan; 71(2):473-83. PubMed ID: 21224350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.
    Pan X; Han H; Wang L; Yang L; Li R; Li Z; Liu J; Zhao Q; Qian M; Liu M; Du B
    Cancer Lett; 2011 Dec; 313(2):181-91. PubMed ID: 21959111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT; Wu CH; Yen GC
    Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.
    Vultur A; Buettner R; Kowolik C; Liang W; Smith D; Boschelli F; Jove R
    Mol Cancer Ther; 2008 May; 7(5):1185-94. PubMed ID: 18483306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.